News

HDA Media And Political Bulletin – 11 March 2016

Government only met with RPS once to discuss funding cuts

C&D, Annabelle Collins, 10 March 2016

 

The RPS has revealed it only met once with the government to discuss funding cuts. Sandra Gidley, RPS board chair, stated that “This is somewhat troubling. It is a very opaque process and has been from the start”.

 

Petition aimed at Cameron gains almost 100,000 signatures

Pharmacy Biz, Neil Trainis, 10 March 2016

 

A petition aimed at David Cameron against the government’s pharmacy cuts and austerity measures has attracted over 100,000 signatures. The NPA stated “This new petition will further intensify efforts to counter the government’s proposals.”

 

Parliamentary Coverage

House of Lords, Written Answers, Pharmacy: Tower Hamlets, 10 March 2016

 

Asked by Lord Mawson: What assessment they have made of the impact of their planned pharmacy cuts on patients and health services in the London Borough of Tower Hamlets.

 

The Parliamentary Under-Secretary of State, Department of Health (Lord Prior of Brampton) (Con):  Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review, the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020-21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.

The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.

We are consulting the Pharmaceutical Services Negotiating Committee, other pharmacy bodies and patient and public representatives on our proposals. An impact assessment will be completed to inform final decisions and published in due course.

NHS England has a statutory duty to ensure the adequate provision of NHS pharmaceutical services across England and will ensure that duty continues to be met, including in respect of the London Borough of Tower Hamlets.

 

House of Lords, Written Answers, Pharmacy, 10 March 2016

 

Asked by Lord Mawson:  What assessment they or NHS England have made of the effectiveness of minor ailments services provided by community pharmacies in reducing pressure on GP practices and other parts of the NHS, and what assessment they have made of the impact of their planned pharmacy cuts on such services

 

The Parliamentary Under-Secretary of State, Department of Health (Lord Prior of Brampton) (Con): NHS England has taken account of the potential impact of a pharmacy minor ailments service on general practitioner services and other parts of the National Health Service. The findings of the Minor Ailment Study (MINA), conducted by the University of Aberdeen, in collaboration with NHS Grampian and the University of East Anglia, on behalf of Pharmacy Research UK in 2014, were considered. The study’s main conclusions were:

– consultations for minor ailments continue to be a burden on high cost service providers but there needs to be consensus amongst healthcare professionals regarding what constitutes a minor ailment suitable for treatment in the community pharmacy setting;

– the evidence considered suggests that community pharmacy-based minor ailment schemes are an effective and cost-effective strategy for managing patients;

– health professionals and patients need to be confident in the ability of pharmacists and their staff to manage minor ailments; and

– future initiatives to shift demand from high cost settings to community pharmacy should adopt an interdisciplinary approach to explore and address patient decision-making behaviour.

In addition, evaluations of local minor ailments schemes have continued to inform decision-making about local commissioning of such schemes.

Community pharmacy is a vital part of the NHS and can play an even greater role. In the Spending Review the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.

The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.

We are consulting the Pharmaceutical Services Negotiating Committee, other pharmacy bodies and patient and public representatives on our proposals. An impact assessment will be completed to inform final decisions and published in due course.

Local commissioning and funding of services from community pharmacies, such as minor ailment services, will be unaffected by these proposals.

 

House of Lords, Written Answers, Medical Equipment: Pharmacy, 10 March 2016

 

Asked by Lord Hunt of Kings Heath: Whether the Rapid Review Panel process can be extended to medical device technology, and if not, why not.

 

The Parliamentary Under-Secretary of State, Department of Health (Lord Prior of Brampton) (Con): The Rapid Review Panel’s (RRP) primary remit is the evaluation of products for potential use in the National Health Service, to support claims of improved efficiency or efficacy of infection prevention and control interventions i.e. products that could reduce healthcare associated infections. The RRP, however, does not have the remit to regulate the safety of therapeutic products such as medical devices.

Due to the requirements of safety assurance and regulation of therapeutic products, which are verified through Notified Bodies applying a <em>Conformité Européenne (</em>CE) marking, medical device technology falls within the remit of the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA’s Innovation Office is set up to assist companies in the regulation of novel medical devices.

 

Full Coverage

Petition aimed at Cameron gains almost 100,000 signatures

Pharmacy Biz, Neil Trainis, 10 March 2016

 

A petition aimed at the Prime Minister David Cameron and launched by the National Pharmacy Association against the government’s pharmacy funding cuts and austerity measures has attracted almost 100,000 signatures, the body has revealed.

 

Two weeks after the petition started it appears good progress is being made and on March 14 independents across England will receive a pack which includes blank petitions, Support Your Local Pharmacy badges and a Support Your Local Pharmacy window poster.

 

“The time to act is now. The petition is a really important element of the campaign, because it gives patients a straightforward opportunity to express their concerns, and we know that support from patients is needed to make the government change from its disastrous course,” said Ian Strachan, chairman of the National Pharmacy Association.

 

The NPA said: “The national pharmacy bodies coordinating the campaign identified the need for a petition of this kind, to complement a parliamentary e-petition which has already gathered tens of thousands of signatures.

 

“This new petition will further intensify efforts to counter the government’s proposals. It will appeal directly to the heart of government: No 10 Downing Street.

 

“It is a paper-based petition rather than an electronic petition; we know that for many people, including elderly patients, this is the preferred way to express their support.”

 

The NPA also said that 200,000 campaign cards, issued to pharmacy staff to send to their MPs, are in circulation.

 

 

Government only met with RPS once to discuss funding cuts

C&D, Annabelle Collins, 10 March 2016

 

The RPS has revealed it only met once with the government to discuss funding cuts. Sandra Gidley, RPS board chair, stated that “This is somewhat troubling. It is a very opaque process and has been from the start”.

 

Petition aimed at Cameron gains almost 100,000 signatures

Pharmacy Biz, Neil Trainis, 10 March 2016

 

A petition aimed at David Cameron against the government’s pharmacy cuts and austerity measures has attracted over 100,000 signatures. The NPA stated “This new petition will further intensify efforts to counter the government’s proposals.”

 

Parliamentary Coverage

House of Lords, Written Answers, Pharmacy: Tower Hamlets, 10 March 2016

 

Asked by Lord Mawson: What assessment they have made of the impact of their planned pharmacy cuts on patients and health services in the London Borough of Tower Hamlets.

 

The Parliamentary Under-Secretary of State, Department of Health (Lord Prior of Brampton) (Con):  Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review, the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020-21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.

The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.

We are consulting the Pharmaceutical Services Negotiating Committee, other pharmacy bodies and patient and public representatives on our proposals. An impact assessment will be completed to inform final decisions and published in due course.

NHS England has a statutory duty to ensure the adequate provision of NHS pharmaceutical services across England and will ensure that duty continues to be met, including in respect of the London Borough of Tower Hamlets.

 

House of Lords, Written Answers, Pharmacy, 10 March 2016

 

Asked by Lord Mawson:  What assessment they or NHS England have made of the effectiveness of minor ailments services provided by community pharmacies in reducing pressure on GP practices and other parts of the NHS, and what assessment they have made of the impact of their planned pharmacy cuts on such services

 

The Parliamentary Under-Secretary of State, Department of Health (Lord Prior of Brampton) (Con): NHS England has taken account of the potential impact of a pharmacy minor ailments service on general practitioner services and other parts of the National Health Service. The findings of the Minor Ailment Study (MINA), conducted by the University of Aberdeen, in collaboration with NHS Grampian and the University of East Anglia, on behalf of Pharmacy Research UK in 2014, were considered. The study’s main conclusions were:

– consultations for minor ailments continue to be a burden on high cost service providers but there needs to be consensus amongst healthcare professionals regarding what constitutes a minor ailment suitable for treatment in the community pharmacy setting;

– the evidence considered suggests that community pharmacy-based minor ailment schemes are an effective and cost-effective strategy for managing patients;

– health professionals and patients need to be confident in the ability of pharmacists and their staff to manage minor ailments; and

– future initiatives to shift demand from high cost settings to community pharmacy should adopt an interdisciplinary approach to explore and address patient decision-making behaviour.

In addition, evaluations of local minor ailments schemes have continued to inform decision-making about local commissioning of such schemes.

Community pharmacy is a vital part of the NHS and can play an even greater role. In the Spending Review the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.

The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.

We are consulting the Pharmaceutical Services Negotiating Committee, other pharmacy bodies and patient and public representatives on our proposals. An impact assessment will be completed to inform final decisions and published in due course.

Local commissioning and funding of services from community pharmacies, such as minor ailment services, will be unaffected by these proposals.

 

House of Lords, Written Answers, Medical Equipment: Pharmacy, 10 March 2016

 

Asked by Lord Hunt of Kings Heath: Whether the Rapid Review Panel process can be extended to medical device technology, and if not, why not.

 

The Parliamentary Under-Secretary of State, Department of Health (Lord Prior of Brampton) (Con): The Rapid Review Panel’s (RRP) primary remit is the evaluation of products for potential use in the National Health Service, to support claims of improved efficiency or efficacy of infection prevention and control interventions i.e. products that could reduce healthcare associated infections. The RRP, however, does not have the remit to regulate the safety of therapeutic products such as medical devices.

Due to the requirements of safety assurance and regulation of therapeutic products, which are verified through Notified Bodies applying a <em>Conformité Européenne (</em>CE) marking, medical device technology falls within the remit of the Medicines and Healthcare products Regulatory Agency (MHRA). The MHRA’s Innovation Office is set up to assist companies in the regulation of novel medical devices.

 

Full Coverage

Petition aimed at Cameron gains almost 100,000 signatures

Pharmacy Biz, Neil Trainis, 10 March 2016

 

A petition aimed at the Prime Minister David Cameron and launched by the National Pharmacy Association against the government’s pharmacy funding cuts and austerity measures has attracted almost 100,000 signatures, the body has revealed.

 

Two weeks after the petition started it appears good progress is being made and on March 14 independents across England will receive a pack which includes blank petitions, Support Your Local Pharmacy badges and a Support Your Local Pharmacy window poster.

 

“The time to act is now. The petition is a really important element of the campaign, because it gives patients a straightforward opportunity to express their concerns, and we know that support from patients is needed to make the government change from its disastrous course,” said Ian Strachan, chairman of the National Pharmacy Association.

 

The NPA said: “The national pharmacy bodies coordinating the campaign identified the need for a petition of this kind, to complement a parliamentary e-petition which has already gathered tens of thousands of signatures.

 

“This new petition will further intensify efforts to counter the government’s proposals. It will appeal directly to the heart of government: No 10 Downing Street.

 

“It is a paper-based petition rather than an electronic petition; we know that for many people, including elderly patients, this is the preferred way to express their support.”

 

The NPA also said that 200,000 campaign cards, issued to pharmacy staff to send to their MPs, are in circulation.

HDA Media And Political Bulletin – 11 March 2016

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?